Day One Biopharmaceuticals, Inc. (DAWN)

NASDAQ: DAWN · Real-Time Price · USD

7.55

+0.14 (1.89%)

At close: Sep 5, 2025, 4:00 PM

7.59

+0.04 (0.53%)

After-hours: Sep 5, 2025, 6:11 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
Medicines for Childhood and Adult Diseases with Equal Intensity	131.16M

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
United States	131.16M